Skip to main content
. 2019 Jul 30;44(2):119–126. doi: 10.5114/ceji.2019.87060

Table 3.

Complications seen in patients and their rates

Complication n Percent
Entire complication* 15 53.5
Pulmonary complications
Bronchiectasis
Asthma
ILD
13
3
7
3
46.4
10.7
25
10.7
Inflammatory bowel disease 3 10.7
Lymphoproliferation 3 10.7
Resistant parasitosis 4 14.3
Growth retardation 4 14.3
Autoimmunity 1 3.6
*

There were more than one complication in some patients, ILD – interstitial lung disease